These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14722459)

  • 1. Red eyes, melting corneas, and gene therapy: some editorial thoughts.
    Cavanagh HD
    Eye Contact Lens; 2004 Jan; 30(1):1. PubMed ID: 14722459
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human tumor necrosis factor receptor Fc fusion protein (Etanercept): experience as a therapy for sight-threatening scleritis and sterile corneal ulceration.
    Hernandez-Illas M; Tozman E; Fulcher SF; Jundt JW; Davis J; Pflugfelder SC
    Eye Contact Lens; 2004 Jan; 30(1):2-5. PubMed ID: 14722460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
    Levy-Clarke G; Jabs DA; Read RW; Rosenbaum JT; Vitale A; Van Gelder RN
    Ophthalmology; 2014 Mar; 121(3):785-96.e3. PubMed ID: 24359625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic targets in psoriasis.
    Kupper TS
    N Engl J Med; 2003 Nov; 349(21):1987-90. PubMed ID: 14627782
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al.
    Matejicka C; Morgan GJ; Schlegelmilch JG
    Arthritis Rheum; 2003 Mar; 48(3):864-6. PubMed ID: 12632456
    [No Abstract]   [Full Text] [Related]  

  • 7. Etanercept for the treatment of severe childhood psoriasis.
    Papoutsaki M; Costanzo A; Mazzotta A; Gramiccia T; Soda R; Chimenti S
    Br J Dermatol; 2006 Jan; 154(1):181-3. PubMed ID: 16403117
    [No Abstract]   [Full Text] [Related]  

  • 8. Barriers to biologics.
    Weinberg JM
    Cutis; 2004 Sep; 74(3):164. PubMed ID: 15499757
    [No Abstract]   [Full Text] [Related]  

  • 9. New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: a personal appraisal of their use in practice.
    Callen JP
    J Am Acad Dermatol; 2003 Aug; 49(2):351-6. PubMed ID: 12894099
    [No Abstract]   [Full Text] [Related]  

  • 10. Two-year follow-up in an early rheumatoid arthritis patient treated with etanercept: radiological involvement despite clinical remission.
    Laganà B; Picchianti Diamanti A; Germano V; Argento G; Ferlito C; D Amelio R
    J Biol Regul Homeost Agents; 2008; 22(4):271-3. PubMed ID: 19036231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pyoderma gangrenosum with etanercept.
    McGowan JW; Johnson CA; Lynn A
    J Drugs Dermatol; 2004; 3(4):441-4. PubMed ID: 15303791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept. Soluble tumour necrosis factor receptor, TNF receptor fusion protein, TNFR-Fc, TNR 001, Enbrel.
    Drugs R D; 1999 Jan; 1(1):75-7. PubMed ID: 10565993
    [No Abstract]   [Full Text] [Related]  

  • 13. Behçet's syndrome: from aetiology to treatment.
    Powell RJ
    Adv Exp Med Biol; 2003; 528():481-6. PubMed ID: 12918749
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Etanercept: enbrel].
    Sparsa A
    Ann Dermatol Venereol; 2007 Dec; 134(12):972-7. PubMed ID: 18166920
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-TNF-alpha therapy in childhood pustular psoriasis.
    Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
    Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept for the management of oral lichen planus.
    Yarom N
    Am J Clin Dermatol; 2007; 8(2):121. PubMed ID: 17428119
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate.
    Foster CS; Tufail F; Waheed NK; Chu D; Miserocchi E; Baltatzis S; Vredeveld CM
    Arch Ophthalmol; 2003 Apr; 121(4):437-40. PubMed ID: 12695239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of etanercept therapy in children with treatment-refractory uveitis.
    Reiff A
    Arthritis Rheum; 2003 Jul; 48(7):2079-80. PubMed ID: 12847709
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept for sleep in patients with alcohol use disorder--mechanisms need to be elucidated.
    Krishnadas R
    Biol Psychiatry; 2010 Jan; 67(1):e1; author reply e3. PubMed ID: 19683705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.